Open AccessAntitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma
Author(s) -
Yasutaka Itashiki,
Koji Harada,
Takanori Takenawa,
Tarannum Ferdous,
Yoshiya Ueyama,
Katsuaki Mishima
Publication year - 2021
Publication title -
oncology letters
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.766
H-Index - 54
eISSN - 1792-1082
pISSN - 1792-1074
DOI - 10.3892/ol.2021.12991
Subject(s) - bevacizumab , angiogenesis , cancer research , medicine , vascular endothelial growth factor , cancer , cd31 , apoptosis , cell growth , cancer cell , cell cycle , pathology , pharmacology , biology , chemotherapy , vegf receptors , biochemistry , genetics